COMPOSITIONS FOR THE TREATMENT OF MYELOFIROSIS
CY1125747T1Undetermined Publication Date: 2026-04-17IMPACT BIOMEDICINES INC
0 Cites 0 Cited by
Patent Information
- Application Number
- CY20221100772T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2010-11-07
- Filing Date
- 2022-12-06
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2042-12-06
Abstract
Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of a compound, which is N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or hydrate thereof.
Need to check novelty before this filing date? Find Prior Art